At day 17 post-tumor inoculation, QBKPN treatment increased the ratio of CD80/CD206 expression on lung macrophages (Fig. 4G), demonstrating an increase in the percentage of M1 lung macrophages. This evidence concerns the gene CD80 and neoplasm.